Table 3.

Adjusted hazard ratios (95% confidence intervals) comparing switchers to dabigatran to warfarin users for the treatment of non-valvular atrial fibrillation

	Number of events			Early (<90 days)	Late (≥90 days)
	Dabigatran	Warfarin	Adjusted hazard ratio (95% CI)	Adjusted hazard ratio (95% CI)	Adjusted hazard ratio (95% CI)
Intracranial bleed	13	110	0.42 (0.23, 0.75)	0.25 (0.06, 1.07)	0.48 (0.25, 0.91)
Ischemic stroke	99	377	1.20 (0.95, 1.51)	0.90 (0.51, 1.59)	1.26 (0.98, 1.61)
Myocardial infarction	105	359	1.24 (0.99, 1.56)	1.33 (0.82, 2.14)	1.23 (0.96, 1.59)
Gastrointestinal bleed	261	649	1.83 (1.58, 2.13)	1.23 (0.96, 1.59)	1.67 (1.40, 1.98)
Hip/pelvic Fracture	96	498	0.89 (0.71, 1.11)	1.02 (0.63, 1.66)	0.85 (0.66, 1.09)

^*Adjusted for age, sex, CHADS₂ score, and propensity score decile